Live Chat

Amgen live chart

instrument_fundamentals

Weekly Search
Weekly
Daily
التاريخ إغلاق معدل التغير معدل التغيير (%) instr__open مرتفع منخفض

أخبار

معلومات

الفارق الهامشي

2.05

الهامش (%)

0.6407 %

الرافعة المالية

1:10

فائدة الشراء بين ليلة وضحاها

-0.0597 %

فائدة البيع بين ليلة وضحاها

-0.0292 %

عملة

USD

ساعات التداول

السوق مغلق

الجمعة

13:31 - 19:59

الاثنين

13:31-19:59

الثلاثاء

13:31-19:59

الأربعاء

13:31-19:59

الخميس

13:31-19:59

instr__analysis_statistics

instr__open

---

instr__close

---

instr__52week_range

--- – ---

instr__market_cap

173240254464

instr__shares_outstand

537329024

instr__earnings_date

1999-11-22

العائد من توزيع الأرباح

2024-09-06

التاريخ السابق لتوزيع الأرباح

2024-08-16

معدل توزيعات الأرباح السنوية الآجلة

9

عائد توزيعات الأرباح السنوية الآجلة

0.0279

instr__eps

5.8

instrument_learn_more

Amgen Amgen Inc
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.

related_instruments

الأصل
البيع
شراء
معدل التغيير (%)
view_all_instruments

Markets.com news

Keep up with the news as it happens and know what’s impacting the markets at any time.

الأربعاء, 9 تِشْرِين ٱلْأَوَّل 2024

أسعار النفط ترتفع بفعل مخاوف الصراع والعاصفة

الأربعاء, 9 تِشْرِين ٱلْأَوَّل 2024

حقل النفط الكازاخستاني الأعلى يسجل إنتاجًا قياسيًا وسط توترات مع أوبك +

الأربعاء, 9 تِشْرِين ٱلْأَوَّل 2024

انخفض الدولار النيوزيلندي بعد التخفيض الكبير في أسعار الفائدة

الأربعاء, 9 تِشْرِين ٱلْأَوَّل 2024

اليوان الصيني ثابت، والأنظار على تحفيز إضافي

Live Chat